Single-port vs laparoscopic surgery for esophageal cancer
Part of Cancer, Digestive system clinical trials.
This study compares two minimally invasive surgical techniques for removing esophageal cancer. It aims to see if the single-port approach is as effective as the standard laparoscopic method, potentially leading to less pain and faster recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with esophageal cancer (confirmed by biopsy) and are scheduled for surgery.
- Your cancer is at an early stage (T1-2N0-1M0), or if it's more advanced (T3N1-2M0), you have received chemo or radiation therapy before surgery and the tumor has shrunk enough to be operable.
- The tumor is located in the part of the esophagus inside the chest.
- The tumor has not spread to nearby vital organs or to distant parts of the body.
- Your major organs (heart, lungs, liver, kidneys) are functioning well enough for surgery under general anesthesia.
- You have not had prior surgery on your esophagus or stomach, and no previous chest surgery that would complicate this procedure.
- You are not currently being treated for another cancer, and you are not participating in other clinical trials.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a less invasive surgical technique to remove part of the esophagus and stomach for esophageal cancer. It aims to see if this approach is safe and effective for patients with early to mid-stage cancer.
This Phase 3 trial compares different “treatments before surgery” for people with esophageal (or esophagus-to-stomach) cancer. It aims to see which approach works better to control the cancer and improve outcomes after surgery.
This trial compares two ways of managing early-stage esophageal cancer after it has been removed through an endoscope: one group has lymph nodes removed (surgery), the other does not. It aims to find out if skipping lymph node removal is safe and effective.
This trial compares robot-assisted surgery with the standard open chest operation to remove esophagus and nearby tissue. It may help you understand which approach works better and is safer for patients whose cancer can be surgically removed.
This trial tests a combination of three drugs (penpulimab, anlotinib, and chemotherapy) given before surgery to shrink esophageal cancer. It is for people with locally advanced cancer who have not had treatment before.
This trial compares two minimally invasive surgical approaches for early-stage stomach cancer affecting the upper portion. Researchers want to see if a newer single-port technique (using one small incision) works as well as traditional laparoscopic surgery (using multiple small incisions) and may cause less pain or faster recovery.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.